ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,848.10
-0.05%
S&P ASX All Technology
3,074.90
-0.10%
Brent Oil
82.025
-0.51%
US Dollar vs AUD
1.50157
0.11%
Bitcoin
70,002.81
-0.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) News

RVMD

Revolution Medicines (RVMD)

Revolution Medicines Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVMD
DateTimeSourceHeadlineSymbolCompany
09/05/202406:02GlobeNewswire Inc.Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate ProgressNASDAQ:RVMDRevolution Medicines Inc
02/05/202406:05GlobeNewswire Inc.Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024NASDAQ:RVMDRevolution Medicines Inc
10/04/202405:34GlobeNewswire Inc.Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) ProteinsNASDAQ:RVMDRevolution Medicines Inc
09/04/202401:36GlobeNewswire Inc.Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) ProteinsNASDAQ:RVMDRevolution Medicines Inc
05/04/202407:05GlobeNewswire Inc.Revolution Medicines to Participate in Upcoming Investor ConferencesNASDAQ:RVMDRevolution Medicines Inc
29/03/202407:05GlobeNewswire Inc.Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024NASDAQ:RVMDRevolution Medicines Inc
06/03/202408:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
06/03/202408:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
06/03/202408:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
05/03/202409:23Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:RVMDRevolution Medicines Inc
27/02/202409:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RVMDRevolution Medicines Inc
27/02/202408:05GlobeNewswire Inc.Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate ProgressNASDAQ:RVMDRevolution Medicines Inc
27/02/202408:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
21/02/202408:05GlobeNewswire Inc.Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024NASDAQ:RVMDRevolution Medicines Inc
10/02/202409:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RVMDRevolution Medicines Inc
02/02/202408:05GlobeNewswire Inc.Revolution Medicines to Participate in Upcoming Investor ConferencesNASDAQ:RVMDRevolution Medicines Inc
25/01/202408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
23/01/202408:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
10/01/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
04/01/202423:00GlobeNewswire Inc.Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RVMDRevolution Medicines Inc
21/12/202309:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
21/12/202309:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
15/12/202310:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
15/12/202309:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
21/11/202310:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
21/11/202308:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
17/11/202306:58Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:RVMDRevolution Medicines Inc
16/11/202308:04Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:RVMDRevolution Medicines Inc
15/11/202312:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
15/11/202312:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:RVMD

Your Recent History

ASX
SAT
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved